15-min delayed · Sep 14, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Medpace Holdings Inc, 2 rate it Buy or better, 7 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $450.00 to $692.00, a moderate spread. The average target of $580.88 sits 3% below the current $595.80. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $4.70 next quarter toward $19.31 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Moderate Buy
Strong Buy00%
Buy222%
Hold778%
Sell00%
Strong Sell00%
Based on 9 analysts giving stock ratings to Medpace Holdings Inc.
As of Sep, 2 of 9 firms rate MEDP a Buy (7 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MEDP EPS & revenue forecast
EPS · NEXT QUARTER
$4.70
Range $4.48 – $4.87 · 8 analysts · +1% YoY
Next period, 8 analysts expect Medpace Holdings Inc to earn $4.70 a share (range $4.48 – $4.87), versus $4.67 a year earlier. Full-year consensus is $17.70, growing to $19.31 the year after.
REVENUE · NEXT QUARTER
$720.4M
Range $708.5M – $737.8M · 8 analysts · +2% YoY
Revenue is expected to reach $720.4M (range $708.5M – $737.8M), +1.7% year-over-year. Full-year consensus is $2.9B, rising to $3.0B next year.
Top analysts covering Medpace Holdings Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MEDP.
#1
Luke Sergott
Barclays · Rank #250
Hold
$450.00-24.5% to target
Overall win rate
41%
+ Follow
#2
RH
Ryan Halsted
RBC Capital
Buy
$692.00+16.1% to target
Coverage
—
+ Follow
#3
EC
Eric Coldwell
Baird
Hold
$624.00+4.7% to target
Coverage
—
+ Follow
#4
Ann Hynes
Mizuho
Buy
$665.00+11.6% to target
Coverage
—
+ Follow
#5
Sean Dodge
BMO Capital
Hold
$600.00+0.7% to target
Coverage
—
+ Follow
MEDP stock forecast FAQ
What is MEDP's average 12-month price target?+
The 8 analysts with a live target average $580.88 for Medpace Holdings Inc over the next 12 months, ranging from a $692.00 high to a $450.00 low.
Is MEDP stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 9 analyst ratings, 2 are Buy or Strong Buy, 7 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for MEDP?+
The Street-high target is $692.00 (RBC Capital), and the Street-low is $450.00 (Barclays). The average of all 8 active targets is $580.88.
How many Wall Street analysts cover MEDP?+
9 analysts have an active rating on Medpace Holdings Inc, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering MEDP?+
Among analysts who currently cover MEDP, Luke Sergott of Barclays has the strongest overall Quantellect track record (Rank #250). Their current call is Hold with a $450.00 target.
What is Medpace Holdings Inc's projected EPS for next quarter?+
The consensus estimate is $4.70 per share (range $4.48 – $4.87) across 8 analysts. Full-year EPS is projected at $17.70, rising to $19.31 the following year.
How much revenue is Medpace Holdings Inc expected to report next quarter?+
Consensus revenue is $720.4M (range $708.5M – $737.8M). Full-year revenue is projected at $2.9B, growing to $3.0B next year.
Have analysts been upgrading or downgrading MEDP lately?+
As of Sep, 2 of 9 firms rate MEDP a Buy (7 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MEDP calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
